Valenzuela, A.; Ayuso, M.; Buyssens, L.; Bars, C.; Van Ginneken, C.; Tessier, Y.; Van Cruchten, S.
Platelet Activation by Antisense Oligonucleotides (ASOs) in the Göttingen Minipig, including an Evaluation of Glycoprotein VI (GPVI) and Platelet Factor 4 (PF4) Ontogeny. Pharmaceutics 2023, 15, 1112.
https://doi.org/10.3390/pharmaceutics15041112
AMA Style
Valenzuela A, Ayuso M, Buyssens L, Bars C, Van Ginneken C, Tessier Y, Van Cruchten S.
Platelet Activation by Antisense Oligonucleotides (ASOs) in the Göttingen Minipig, including an Evaluation of Glycoprotein VI (GPVI) and Platelet Factor 4 (PF4) Ontogeny. Pharmaceutics. 2023; 15(4):1112.
https://doi.org/10.3390/pharmaceutics15041112
Chicago/Turabian Style
Valenzuela, Allan, Miriam Ayuso, Laura Buyssens, Chloé Bars, Chris Van Ginneken, Yann Tessier, and Steven Van Cruchten.
2023. "Platelet Activation by Antisense Oligonucleotides (ASOs) in the Göttingen Minipig, including an Evaluation of Glycoprotein VI (GPVI) and Platelet Factor 4 (PF4) Ontogeny" Pharmaceutics 15, no. 4: 1112.
https://doi.org/10.3390/pharmaceutics15041112
APA Style
Valenzuela, A., Ayuso, M., Buyssens, L., Bars, C., Van Ginneken, C., Tessier, Y., & Van Cruchten, S.
(2023). Platelet Activation by Antisense Oligonucleotides (ASOs) in the Göttingen Minipig, including an Evaluation of Glycoprotein VI (GPVI) and Platelet Factor 4 (PF4) Ontogeny. Pharmaceutics, 15(4), 1112.
https://doi.org/10.3390/pharmaceutics15041112
